Document resource
The cost effectiveness thresholds used to evaluate whether new medicines can be rolled out on the NHS are set to rise after pressure from the US.
Annotated abstract
UK-US pharmaceutical deal: NHS will pay billions more for new drugs
bmj · 2025-12-02 · canonical JSON source